Literature DB >> 15771652

The impact of social support on end-stage renal disease.

Samir S Patel1, Rolf A Peterson, Paul L Kimmel.   

Abstract

Social support is a concept recognizing patients exist to varying degrees in networks through which they can receive and give aid, and in which they engage in interactions. Social support can be obtained from family, friends, coworkers, spiritual advisors, health care personnel, or members of one's community or neighborhood. Several studies have demonstrated that social support is associated with improved outcomes and improved survival in several chronic illnesses, including cancer and end-stage renal disease (ESRD). The mechanism by which social support exerts its salutary effects are unknown, but practical aid in achieving compliance, better access to health care, improved psychosocial and nutritional status and immune function, and decreased levels of stress may all play key roles. Few data exist regarding social support in patients with ESRD and chronic renal insufficiency, but links between social support and depressive affect and quality of life have been established. Interventions that enhance social support in ESRD patients should be evaluated.

Entities:  

Mesh:

Year:  2005        PMID: 15771652     DOI: 10.1111/j.1525-139X.2005.18203.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  41 in total

Review 1.  A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease.

Authors:  S Susan Hedayati; Venkata Yalamanchili; Fredric O Finkelstein
Journal:  Kidney Int       Date:  2011-10-19       Impact factor: 10.612

2.  A longitudinal examination of social support, agreeableness and depressive symptoms in chronic kidney disease.

Authors:  Karin F Hoth; Alan J Christensen; Shawna L Ehlers; Katherine A Raichle; William J Lawton
Journal:  J Behav Med       Date:  2007-01-12

3.  Mental and physical symptoms associated with lower social support for patients with hepatitis C.

Authors:  Julie A Blasiole; Laura Shinkunas; Douglas R Labrecque; Robert M Arnold; Susan L Zickmund
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

Review 4.  Depression and mortality in end-stage renal disease.

Authors:  Nisha Ver Halen; Daniel Cukor; Melissa Constantiner; Paul L Kimmel
Journal:  Curr Psychiatry Rep       Date:  2012-02       Impact factor: 5.285

Review 5.  The psychosocial correlates of quality of life in the dialysis population: a systematic review and meta-regression analysis.

Authors:  Ramony Chan; Robert Brooks; Zachary Steel; Tracy Heung; Jonathan Erlich; Josephine Chow; Michael Suranyi
Journal:  Qual Life Res       Date:  2011-07-31       Impact factor: 4.147

6.  Spirituality in the Lives of Patients with End-Stage Renal Disease: A Systematic Review.

Authors:  Suhair Hussni Al-Ghabeesh; Ali Ahmad Alshraifeen; Ahmad Rajeh Saifan; Ibraheem Hassan Bashayreh; Karimeh Mousa Alnuaimi; Haya Ali Masalha
Journal:  J Relig Health       Date:  2018-12

7.  Impact of Uraemic Pruritus on Quality of Life among End Stage Renal Disease Patients on Dialysis.

Authors:  Mohamed K Ibrahim; Ahmed R Elshahid; Tarek Z El Baz; Raed M Elazab; Sara A Elhoseiny; Mohamed L Elsaie
Journal:  J Clin Diagn Res       Date:  2016-03-01

8.  Disaster Preparedness and Awareness of Patients on Hemodialysis after Hurricane Sandy.

Authors:  Naoka Murakami; Hira Babu Siktel; David Lucido; James F Winchester; Nikolas B Harbord
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-28       Impact factor: 8.237

9.  Promoting access to renal transplantation: the role of social support networks in completing pre-transplant evaluations.

Authors:  Cheryl R Clark; Leroi S Hicks; Joseph H Keogh; Arnold M Epstein; John Z Ayanian
Journal:  J Gen Intern Med       Date:  2008-05-14       Impact factor: 5.128

10.  A palliative approach to dialysis care: a patient-centered transition to the end of life.

Authors:  Vanessa Grubbs; Alvin H Moss; Lewis M Cohen; Michael J Fischer; Michael J Germain; S Vanita Jassal; Jeffrey Perl; Daniel E Weiner; Rajnish Mehrotra
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-07       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.